Ireland
--:--IST
Latest
Clinical Trials in Poland / NCT07779161
Starting soon Not applicable

Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance

NCT07779161 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2026-08
Last updated
2026-08-21

Condition(s) studied

Behavioral InterventionNicotine Addiction

Investigational drug(s) / intervention(s)

Standard phone callphone call with MINDSPACE elements

Standard phone call: Participants will receive a phone call from a trained staff member 1-5 days before the appointment. The conversation will follow a strictly standardized script limited solely to confirming the appointment date, without any motivational or therapeutic elements.

phone call with MINDSPACE elements: Participants will receive a phone call 1-5 days before their appointment. The conversation will follow a standardized script incorporating behavioral intervention (nudging) elements based on the MINDSPACE framework. Key components of the script include: * Messenger (Sender): Emphasizing that the information comes from the medical team. * Norms (Social Norms): Referring to success statistics for regular visits. * Commitment: Encouraging verbal confirmation of attendance. * Affect (Emotions): Providing short messages reinforcing a sense of support.

Study summary

The goal of this clinical trial is to learn whether different appointment reminder methods can improve attendance at an anti-smoking (smoking cessation) clinic among adult smokers.

The main question it aims to answer is:

"Which reminder method helps participants come to their scheduled smoking cessation clinic appointments most often?" Researchers will compare different appointment reminder methods with standard appointment scheduling to see if they help participants attend their clinic visits more often.

Participants will:

* Receive appointment reminders using different methods
* Come to their scheduled visits at a smoking cessation (anti-nicotine) clinic

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years. Confirmed diagnosis of nicotine dependence (F17 according to the International Classification of Diseases, 10th Revision \[ICD-10\]) and active patient status at the Smoking Cessation Clinic. * Provision of voluntary, written, informed consent to participate in the study and to be contacted by telephone or short text message. * Ability to independently provide information and operate a mobile phone. * At the time of study enrollment, attendance at an initial visit at the clinic. Exclusion Criteria * Age \< 18 years. * Lack of written, informed consent to participate in the study. * Inability to independently understand the study procedures or provide responses (e.g., due to dementia or a language barrier).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Clinical Centre Gdansk Pomeranian Voivodeship

More Medical University of Gdansk trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07779161 on ClinicalTrials.gov ↗ ← All trials in Poland